22157.jpg
Insights on the Bacteriophage Global Market to 2026 - Players Include Phage Biotech, InnoPhage and EnBiotix Among Others
July 23, 2021 07:23 ET | Research and Markets
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "Bacteriophage Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Bacteriophage Market Report 2021: North America Remains the Market Leader - Forecast to 2029
June 21, 2021 07:28 ET | Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Bacteriophage Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021...
ContraFect Awarded Funding from CARB-X to Support Gram-Negative Lysin Program
March 30, 2017 11:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - March 30, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
ContraFect Presents New CF-301 Data at ASM Microbe 2016
June 21, 2016 07:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - June 21, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces Presentation of Data at ASM Microbe 2016
June 08, 2016 07:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - June 08, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces First Quarter 2016 Results
May 10, 2016 07:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - May 10, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016
May 03, 2016 07:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - May 03, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and...
ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference
March 29, 2016 07:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - March 29, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and...
ContraFect Announces Fourth Quarter and Full Year 2015 Results
March 15, 2016 07:00 ET | ContraFect Corporation
YONKERS, NY--(Marketwired - March 15, 2016) -  ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Conference as Part of a Collaboration With Phage Pharmaceuticals
June 11, 2012 16:30 ET | Avid Bioservices
TUSTIN, CA--(Marketwire - Jun 11, 2012) - Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will collaborate with San Diego-based Phage...